Trials / Conditions / Philadelphia Chromosome

Philadelphia Chromosome

7 registered clinical trials studyying Philadelphia Chromosome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patient NCT06220487	Nanfang Hospital, Southern Medical University	Phase 2
Completed	Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Pat NCT05433532	The First Affiliated Hospital of Soochow University	Phase 2
Completed	Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leuk NCT03509896	Bristol-Myers Squibb	—
Completed	Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phas NCT01511289	Il-Yang Pharm. Co., Ltd.	Phase 3
Completed	Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI NCT01602952	Il-Yang Pharm. Co., Ltd.	Phase 1 / Phase 2
Completed	Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Chil NCT00287105	Rennes University Hospital	Phase 2
Completed	Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive NCT00763763	Assistance Publique - Hôpitaux de Paris	Phase 2